Clinical Trial Update: Clinical Study of Recombinant Novel Coronavirus Vaccine [Phase 2]

View source ↗

Summary

Phase 2 clinical study update for a recombinant novel coronavirus vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus

Drugs mentioned

• Recombinant novel coronavirus vaccine

Snippet

Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Conditions: Coronavirus | Phase 2 | Status: UNKNOWN